Global Expansion Opportunity ProPharma Group is expanding its global footprint with new offices in Hyderabad, India, and has recently launched a proprietary tool to accelerate regulatory submissions. Leverage this momentum to upsell additional regulatory, pharmacovigilance, and medical writing services to multinational pharma clients seeking efficient global submissions and 24/7 support.

AI and Innovation The company has earned industry recognition for AI-driven capabilities in medical information and recently launched an in-house proprietary tool. Position high-value AI-enabled solutions for faster case handling, smarter adverse event processing, and enhanced regulatory compliance to target mid-to-large pharma and biotech firms investing in digital transformation.

Expanded Service Suite With offerings spanning medical information, pharmacovigilance, medical writing, translations, and conference coverage, ProPharma Group provides a broad service base. Use cross-selling playbooks to bundle pharmacovigilance with labeling, regulatory submissions, and clinical documentation support for end-to-end lifecycle management.

Leadership and Talent Growth Recent leadership hire as Chief Commercial Officer and expansion of PV scientists in Hyderabad indicate a focus on commercial growth and regional capability build. Target similar life sciences organizations undergoing leadership-led sales transformations and identify opportunities to partner on regulatory, labeling, and PV service enhancements.

Midmarket Focus Reported revenue in the $1M-$10M range with 201-500 employees and a global delivery model. Align outreach to small- to mid-sized biotechs and midsize pharma companies seeking scalable PV, regulatory, and medical writing support, including flexible FSP services and 24/7 multilingual information delivery.